Developing autoantibody signatures to predict disease recurrence and immune-related adverse events in patients receiving adjuvant immunotherapy
18 Jun 2024
Salon B
Immune Biomarkers
)
- Do autoantibody signatures / biomarkers offer advantages over DNA, RNA and protein
- biomarkers?
- Can autoantibody profiles be used as a tool for treatment monitoring?
- What are the best approaches for identifying autoantibody signatures?
- What are the preferred platforms for discovering and validating autoantibody signatures?
Industry Expert
